{
  "company": "Novartis AG",
  "pillarDetails": {
    "Transparency": {
      "score": 1,
      "justification": "Score = 1 because 2 source(s) (listed below) contain detailed, verifiable information.",
      "relevantSources": [
        {
          "url": "https://www.novartis.com/sites/novartiscom/files/novartis-responsible-use-of-ai-systems.pdf",
          "title": "Novartis' commitment to the ethical and responsible use of Artficial Intelligence Systems",
          "summary": "Details Novartis AI transparency principles including disclosure when users interact with AI systems.",
          "documentType": "PDF",
          "retrievedAt": "2025-07-23",
          "sourceUsed": true,
          "evaluation": "This official company policy document includes explicit, actionable requirements for AI transparency, disclosure practices, and auditability."
        },
        {
          "url": "https://www.novartis.com/esg/ethics-risk-and-compliance/compliance/our-commitment-ethical-and-responsible-use-artificial-intelligence-ai",
          "title": "Our commitment to ethical and responsible use of Artificial Intelligence (AI)",
          "summary": "Web page outlining commitment to transparent AI deployment and clear purpose disclosure.",
          "documentType": "Web Page",
          "retrievedAt": "2025-07-23",
          "sourceUsed": true,
          "evaluation": "The web page describes in detail the practical transparency standards and human-centered approach implemented for AI systems."
        }
      ],
      "findings": "Novartis has established concrete standards around AI system transparency, requiring user disclosure and clear communication of system limitations. Their documentation also mandates auditability and transparency in model decision-making, with verifiable policies detailing these expectations."
    },
    "Fairness & Bias Mitigation": {
      "score": 1,
      "justification": "Score = 1 because 1 source(s) (listed below) contain detailed, verifiable information.",
      "relevantSources": [
        {
          "url": "https://www.novartis.com/careers/career-search/job/details/req-10047107-director-responsible-ai",
          "title": "Director, Responsible AI",
          "summary": "Job posting detailing responsibilities for AI fairness assessment and bias mitigation frameworks.",
          "documentType": "Web Page",
          "retrievedAt": "2025-07-23",
          "sourceUsed": true,
          "evaluation": "The job description mandates development and enforcement of detailed frameworks for AI fairness and explicit, measurable bias mitigation procedures."
        }
      ],
      "findings": "The company dedicates specific leadership roles to AI fairness and mitigation of bias, detailing frameworks and governance for ensuring AI solutions are fair, transparent, and upheld to ethical standards. Explicit processes, procedures, and review mechanisms are described, addressing the concrete requirements of fairness and bias reduction."
    },
    "Explainability": {
      "score": 1,
      "justification": "Score = 1 because 2 source(s) (listed below) contain detailed, verifiable information.",
      "relevantSources": [
        {
          "url": "https://oak.novartis.com/49396/",
          "title": "Explaining compound activity predictions with a substructure-aware loss for graph neural networks.",
          "summary": "Research paper on explainable machine learning for drug discovery compound property predictions.",
          "documentType": "Journal Article",
          "retrievedAt": "2025-07-23",
          "sourceUsed": true,
          "evaluation": "This journal article describes and benchmarks methods for explainability in graph neural networks used by Novartis, presenting empirical results and best practices."
        },
        {
          "url": "https://emerj.com/driving-patient-experiences-through-data-science-driven-approaches-to-infrastructure-xiong-liu-novartis/",
          "title": "Driving Patient Experiences Through Data Science-Driven Approaches to Infrastructure - with Xiong Liu of Novartis - Emerj Artificial Intelligence Research",
          "summary": "Interview discussing explainable AI models and knowledge graphs for pharmaceutical R&D transparency.",
          "documentType": "Web Page",
          "retrievedAt": "2025-07-23",
          "sourceUsed": true,
          "evaluation": "The discussion details specific explainability methodologies implemented in pharmaceutical R&D, such as knowledge graphs and interpretability in prediction."
        }
      ],
      "findings": "Novartis applies advanced explainability methods in its AI-driven drug discovery workflows. The referenced research and expert discussions reveal the company's use of scientific approaches—like feature attribution techniques, explainable GNNs, and knowledge graphs—to yield transparent decision support, fostering trust among decision-makers."
    },
    "Human Oversight & Accountability": {
      "score": 1,
      "justification": "Score = 1 because 1 source(s) (listed below) contain detailed, verifiable information.",
      "relevantSources": [
        {
          "url": "https://www.novartis.com/careers/career-search/job/details/req-10047107-director-responsible-ai",
          "title": "Director, Responsible AI",
          "summary": "Job posting detailing responsibilities for AI fairness assessment and bias mitigation frameworks.",
          "documentType": "Web Page",
          "retrievedAt": "2025-07-23",
          "sourceUsed": true,
          "evaluation": "This position controls the implementation of responsible AI governance with explicit references to procedural accountability, oversight, and risk management."
        }
      ],
      "findings": "Novartis has put in place explicit structures for human oversight and accountability in AI deployment. The company has designated leadership positions tasked with maintaining control, overseeing governance, and ensuring adherence to responsible design, review, and operation of AI systems."
    },
    "Privacy & Security": {
      "score": 1,
      "justification": "Score = 1 because 1 source(s) (listed below) contain detailed, verifiable information.",
      "relevantSources": [
        {
          "url": "https://live.novartis.com/en/article/protecting-privacy-in-an-ai-driven-world",
          "title": "AI Data Privacy: Safeguarding Personal Data",
          "summary": "Article discussing AI compliance and transparency requirements for data protection.",
          "documentType": "Web Page",
          "retrievedAt": "2025-07-23",
          "sourceUsed": true,
          "evaluation": "This in-depth article explains the company's approach to AI data privacy, compliance, and protection in practical, actionable terms."
        }
      ],
      "findings": "Novartis identifies privacy and security as essential elements of its AI practice, describing how roles and systems enforce personal data protection, regulatory compliance, and privacy-by-design in AI-enabled processes."
    },
    "Governance & Accountability": {
      "score": 1,
      "justification": "Score = 1 because 2 source(s) (listed below) contain detailed, verifiable information.",
      "relevantSources": [
        {
          "url": "https://www.novartis.com/sites/novartiscom/files/novartis-ethical-use-of-data-technology-policy.pdf",
          "title": "Ethical Use of Data and technology",
          "summary": "Policy document requiring transparency in data collection and AI system use.",
          "documentType": "PDF",
          "retrievedAt": "2025-07-23",
          "sourceUsed": true,
          "evaluation": "The policy document provides specific, enforceable obligations and governance principles for the use of AI at Novartis."
        },
        {
          "url": "https://www.novartis.com/sites/novartiscom/files/novartis-q3-2024-impact-and-sustainability-update.pdf",
          "title": "Q3 2024 Impact and Sustainability Update to investors",
          "summary": "Update on responsible AI implementation emphasizing ethical AI approach and bias prevention.",
          "documentType": "PDF",
          "retrievedAt": "2025-07-23",
          "sourceUsed": true,
          "evaluation": "This report illustrates tangible governance and oversight mechanisms executed by the company and updates stakeholders on the status."
        }
      ],
      "findings": "Novartis outlines a clear governance structure, codified in policy, that addresses responsibility, risk assessment, and enforcement in AI development and use. Sustainability and impact reports corroborate their practical application and ongoing oversight of AI governance."
    },
    "Public Commitments & External Audits": {
      "score": 0,
      "justification": "Score = 0 because none of the researched sources address Public Commitments & External Audits in any meaningful way.",
      "relevantSources": [
        {
          "url": "No relevant sources found",
          "title": null,
          "summary": null,
          "documentType": null,
          "retrievedAt": null,
          "sourceUsed": false,
          "evaluation": "None of the sources provided concrete, verifiable information about public external audits or specific public commitments beyond vague or partnership announcements."
        }
      ],
      "findings": "No public evidence found for this pillar."
    }
  },
  "aggregate": {
    "totalScoreOutOf7": 6,
    "percentScore": 85.7,
    "starRating": 4.0,
    "starString": "★★★★☆"
  },
  "summary": {
    "starString": "★★★★★",
    "keyStrengths": [
      "Transparency",
      "Fairness & Bias Mitigation",
      "Explainability",
      "Human Oversight & Accountability",
      "Privacy & Security",
      "Governance & Accountability"
    ],
    "keyGaps": [
      "Public Commitments & External Audits"
    ],
    "sourcesUsed": [
      {
        "url": "https://www.novartis.com/sites/novartiscom/files/novartis-responsible-use-of-ai-systems.pdf",
        "title": "Novartis' commitment to the ethical and responsible use of Artficial Intelligence Systems",
        "summary": "Details Novartis AI transparency principles including disclosure when users interact with AI systems.",
        "documentType": "PDF",
        "retrievedAt": "2025-07-23",
        "sourceUsed": true,
        "evaluation": "This official company policy document includes explicit, actionable requirements for AI transparency, disclosure practices, and auditability."
      },
      {
        "url": "https://www.novartis.com/esg/ethics-risk-and-compliance/compliance/our-commitment-ethical-and-responsible-use-artificial-intelligence-ai",
        "title": "Our commitment to ethical and responsible use of Artificial Intelligence (AI)",
        "summary": "Web page outlining commitment to transparent AI deployment and clear purpose disclosure.",
        "documentType": "Web Page",
        "retrievedAt": "2025-07-23",
        "sourceUsed": true,
        "evaluation": "The web page describes in detail the practical transparency standards and human-centered approach implemented for AI systems."
      },
      {
        "url": "https://www.novartis.com/careers/career-search/job/details/req-10047107-director-responsible-ai",
        "title": "Director, Responsible AI",
        "summary": "Job posting detailing responsibilities for AI fairness assessment and bias mitigation frameworks.",
        "documentType": "Web Page",
        "retrievedAt": "2025-07-23",
        "sourceUsed": true,
        "evaluation": "The job description mandates development and enforcement of detailed frameworks for AI fairness and explicit, measurable bias mitigation procedures."
      },
      {
        "url": "https://oak.novartis.com/49396/",
        "title": "Explaining compound activity predictions with a substructure-aware loss for graph neural networks.",
        "summary": "Research paper on explainable machine learning for drug discovery compound property predictions.",
        "documentType": "Journal Article",
        "retrievedAt": "2025-07-23",
        "sourceUsed": true,
        "evaluation": "This journal article describes and benchmarks methods for explainability in graph neural networks used by Novartis, presenting empirical results and best practices."
      },
      {
        "url": "https://emerj.com/driving-patient-experiences-through-data-science-driven-approaches-to-infrastructure-xiong-liu-novartis/",
        "title": "Driving Patient Experiences Through Data Science-Driven Approaches to Infrastructure - with Xiong Liu of Novartis - Emerj Artificial Intelligence Research",
        "summary": "Interview discussing explainable AI models and knowledge graphs for pharmaceutical R&D transparency.",
        "documentType": "Web Page",
        "retrievedAt": "2025-07-23",
        "sourceUsed": true,
        "evaluation": "The discussion details specific explainability methodologies implemented in pharmaceutical R&D, such as knowledge graphs and interpretability in prediction."
      },
      {
        "url": "https://live.novartis.com/en/article/protecting-privacy-in-an-ai-driven-world",
        "title": "AI Data Privacy: Safeguarding Personal Data",
        "summary": "Article discussing AI compliance and transparency requirements for data protection.",
        "documentType": "Web Page",
        "retrievedAt": "2025-07-23",
        "sourceUsed": true,
        "evaluation": "This in-depth article explains the company's approach to AI data privacy, compliance, and protection in practical, actionable terms."
      },
      {
        "url": "https://www.novartis.com/sites/novartiscom/files/novartis-ethical-use-of-data-technology-policy.pdf",
        "title": "Ethical Use of Data and technology",
        "summary": "Policy document requiring transparency in data collection and AI system use.",
        "documentType": "PDF",
        "retrievedAt": "2025-07-23",
        "sourceUsed": true,
        "evaluation": "The policy document provides specific, enforceable obligations and governance principles for the use of AI at Novartis."
      },
      {
        "url": "https://www.novartis.com/sites/novartiscom/files/novartis-q3-2024-impact-and-sustainability-update.pdf",
        "title": "Q3 2024 Impact and Sustainability Update to investors",
        "summary": "Update on responsible AI implementation emphasizing ethical AI approach and bias prevention.",
        "documentType": "PDF",
        "retrievedAt": "2025-07-23",
        "sourceUsed": true,
        "evaluation": "This report illustrates tangible governance and oversight mechanisms executed by the company and updates stakeholders on the status."
      }
    ],
    "overallFindings": "Novartis demonstrates strong, concrete evidence of responsible AI practices in Transparency, Fairness & Bias Mitigation, Explainability, Human Oversight & Accountability, Privacy & Security, and Governance & Accountability. These areas are supported by detailed internal policies, research, official role assignments, and comprehensive governance processes, showing a mature approach to AI stewardship. The only notable gap is the lack of public evidence regarding external audits or formal public commitments beyond high-level statements. Overall, Novartis's documentation and implementation of responsible AI principles are robust and verifiable."
  }
}